Close

WASL

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

WASL (Wiskott-Aldrich Syndrome Like) is a protein-coding gene encodes a member of the Wiskott-Aldrich syndrome (WAS) protein family. Wiskott-Aldrich syndrome proteins share similar domain structure, and associate with a variety of signaling molecules to alter the actin cytoskeleton. Diseases associated with WASL include Wiskott-Aldrich Syndrome and Vaccinia. An important paralog of this gene is WAS.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-WJ2110 Anti-WASL (30D10) h(41BB-CD3ζ) CAR, pCDCAR1 30D10 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ2111 Anti-WASL (CBWJN-0570) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBWJN-0570 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ2112 Anti-WASL (CBWJN-1703) h(41BB-CD3ζ) CAR, pCDCAR1 CBWJN-1703 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ4402 Anti-WASL (30D10) h(CD28-CD3ζ) CAR, pCDCAR1 30D10 Rabbit scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ4403 Anti-WASL (CBWJN-0570) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBWJN-0570 Rabbit scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ4404 Anti-WASL (CBWJN-1703) h(CD28-CD3ζ) CAR, pCDCAR1 CBWJN-1703 Rabbit scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.